FEATURED ARTICLES

• Illuminating The Pathway To Efficient Drug Development For Small Biotechs

  To guide a biotech through successful drug development, there are three key areas a CDMO should focus on: equipment and instrumentation, organization and personnel, and systems and processes.

• Is Your Lab Ready For A LIMS Implementation?
• Bacterial Endotoxin Testing, Part 2: Prerequisites & Reagent Preparation
• Bacterial Endotoxin Testing, Part 1: Overview
• How DFM Promotes Scalability, Repeatability, And Profitability

WHITE PAPERS & CASE STUDIES

• Microbial Challenge In-Use Studies

  Learn more about how a partner with expertise can help you navigate the complex landscape of microbial challenge in-use studies and ensure the highest standards of patient care.

• Accelerating SARS-CoV-2 Immunotherapy Speed To Clinic

  A clinical-stage biotherapeutics company developing a COVID-19 immunotherapy searched for a solution to the difficulties it faced in scaling up its manufacturing operations due to limited resources.

• Extractables And Leachables Testing

  Learn how to navigate the extractables and leachables regulatory landscape and implement best practices for leachables analysis in your pharmaceutical development process.

• Manufacturing Challenges With High Concentration Biologics

  Explore key process operations, some of the challenges in manufacturing high-concentration biologics, and factors to consider for process optimization.

• Could RFID-Based Unit-Level Traceability Be Key To Operational Excellence?

  Radiofrequency identification (RFID)-based unit-level tracking solutions for prefilled syringes are poised to help pharma manufacturers address key risks and costly bottlenecks related to the fill-finish process.

• Electron Activated Dissociation Workflow For Biotherapeutics Characterization

  Explore the benefits of an electron-activated dissociation middle-down workflow, including the ability to achieve high sequence coverages (70%-80%) of monoclonal antibody subunits in a single injection.